For the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal
and hock joints in horses.
IMPORTANT SAFETY INFORMATION
There are no known contraindications to the use of intramuscular Adequan® i.m. brand Polysulfated Glycosaminoglycan in horses. Studies
have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not
for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on
the order of a licensed veterinarian.
Please see Full Prescribing Information at www.adequan.com.
Adequan® and the Horse Head design are registered trademarks of Luitpold Pharmaceuticals, Inc.
© Luitpold Animal Health, division of Luitpold Pharmaceuticals, Inc. 2016. AHD227 Iss. 4/2016
NO GENERIC ADEQUAN®
The ONLY FDA approved equine PSGAG for the intramuscular treatment of non-infectious degenerative
joint disease (DJD) of the carpal and hock joints proven to:
• DIMINISH the destructive processes of degenerative joint disease
• REVERSE the processes which result in the loss of cartilage components
• IMPROVE overall joint function and associated lameness
Available for order! For more information about equine joint health and treatment with Adequan® i.m.,
please visit www.adequan.com.